News

In a head-to-head clinical trial, Eli Lilly’s Zepbound appears to have delivered superior weight loss outcomes compared with Novo Nordisk’s Wegovy. The trial was conducted

Representatives from over 110 countries have gathered for the inaugural Global Oral Health Conference, organized by the World Health Organization (WHO), with the goal of

Amgen addressed concerns regarding its experimental weight loss drug, MariTide, following a significant drop in its market value. The stock of the company dropped more

The first case of severe mpox in the United States was confirmed by health officials to have occurred in a traveler returning from eastern Africa.

A veteran of the Canadian Forces who has served in Afghanistan believes Canada should be an international leader in discovering alternative treatments for post-traumatic stress

A recent study published in The New England Journal of Medicine avers that a semaglutide weight management drug, Wegovy by Novo Nordisk, can help relieve

On Monday, Oracle Corporation said that it would join the federal-medically backed network known as Trusted Exchange Framework and Common Agreement, or TEFCA. The company

GE HealthCare launched the CareIntellect for Oncology, an artificial intelligence application designed to rescue oncologists from much hassle in the diagnosis and treatment of cancer

Microsoft Corp. has revealed a new suite of artificial intelligence tools on Thursday, which it says could ease the administrative burden on doctors and nurses.

Royal Philips, global health technology leader, and Siloam Hospitals Group, the leading private healthcare provider in Indonesia, signed a Memorandum of Understanding to advance artificial